v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid in Capital
Retained Earnings
Unallocated Common Stock of ESOP
Accumulated Other Comprehensive Income (Loss)
Total
Balance at beginning of period at Dec. 31, 2024 $ 260 $ 114,113 $ 194,188 $ (9,551) $ 5,543 $ 304,553
Balance at beginning of period (in shares) at Dec. 31, 2024 25,978,904          
Increase (Decrease) in Shareholder's Equity            
Net income     5,763     5,763
Other comprehensive loss / income         1,458 1,458
ESOP shares committed to be released   (23)   171   148
Stock-based compensation expense   351       351
Restricted stock awards granted (in shares) 5,000          
Repurchases of common stock $ (2)   (1,570)     (1,572)
Repurchases of common stock (in shares) (130,813)          
Balance at end of period at Mar. 31, 2025 $ 258 114,441 198,381 (9,380) 7,001 310,701
Balance at end of period (in shares) at Mar. 31, 2025 25,853,091          
Balance at beginning of period at Dec. 31, 2024 $ 260 114,113 194,188 (9,551) 5,543 304,553
Balance at beginning of period (in shares) at Dec. 31, 2024 25,978,904          
Increase (Decrease) in Shareholder's Equity            
Net income           12,214
Other comprehensive loss / income           1,509
Balance at end of period at Jun. 30, 2025 $ 255 114,771 201,381 (9,210) 7,052 314,249
Balance at end of period (in shares) at Jun. 30, 2025 25,557,955          
Balance at beginning of period at Mar. 31, 2025 $ 258 114,441 198,381 (9,380) 7,001 310,701
Balance at beginning of period (in shares) at Mar. 31, 2025 25,853,091          
Increase (Decrease) in Shareholder's Equity            
Net income     6,451     6,451
Other comprehensive loss / income         51 51
ESOP shares committed to be released   (24)   170   146
Stock-based compensation expense   354       354
Repurchases of common stock $ (3)   (3,306)     (3,309)
Repurchases of common stock (in shares) (282,836)          
Purchase of employee restricted shares to fund statutory tax withholdings     (145)     (145)
Purchase of employee restricted shares to fund statutory tax withholdings (in shares) (12,300)          
Balance at end of period at Jun. 30, 2025 $ 255 114,771 201,381 (9,210) 7,052 314,249
Balance at end of period (in shares) at Jun. 30, 2025 25,557,955          
Balance at beginning of period at Dec. 31, 2025 $ 251 115,400 203,045 (8,868) 14,033 $ 323,861
Balance at beginning of period (in shares) at Dec. 31, 2025 25,072,214         25,072,214
Increase (Decrease) in Shareholder's Equity            
Net income     5,290     $ 5,290
Other comprehensive loss / income         (1,152) (1,152)
ESOP shares committed to be released   9   170   179
Stock-based compensation expense   360       360
Stock options exercised   47       47
Stock options exercised (shares) 5,000          
Purchase of employee restricted shares to fund statutory tax withholdings (in shares) (413)          
Balance at end of period at Mar. 31, 2026 $ 251 115,816 208,335 (8,698) 12,881 328,585
Balance at end of period (in shares) at Mar. 31, 2026 25,076,801          
Balance at beginning of period at Dec. 31, 2025 $ 251 115,400 203,045 (8,868) 14,033 $ 323,861
Balance at beginning of period (in shares) at Dec. 31, 2025 25,072,214         25,072,214
Increase (Decrease) in Shareholder's Equity            
Net income           $ 8,774
Other comprehensive loss / income           (1,895)
Balance at end of period at Jun. 30, 2026 $ 248 116,284 208,196 (8,528) 12,138 $ 328,338
Balance at end of period (in shares) at Jun. 30, 2026 24,841,663         24,841,663
Balance at beginning of period at Mar. 31, 2026 $ 251 115,816 208,335 (8,698) 12,881 $ 328,585
Balance at beginning of period (in shares) at Mar. 31, 2026 25,076,801          
Increase (Decrease) in Shareholder's Equity            
Net income     3,484     3,484
Other comprehensive loss / income         (743) (743)
ESOP shares committed to be released   22   170   192
Stock-based compensation expense   446       446
Stock options exercised (shares) 1,870          
Restricted stock awards granted (in shares) 5,000          
Repurchases of common stock $ (3)   (3,467)     (3,470)
Repurchases of common stock (in shares) (231,609)          
Purchase of employee restricted shares to fund statutory tax withholdings     (156)     (156)
Purchase of employee restricted shares to fund statutory tax withholdings (in shares) (10,399)          
Balance at end of period at Jun. 30, 2026 $ 248 $ 116,284 $ 208,196 $ (8,528) $ 12,138 $ 328,338
Balance at end of period (in shares) at Jun. 30, 2026 24,841,663         24,841,663